The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS

Journal Title: International Journal of Reproductive BioMedicine - Year 2016, Vol 14, Issue 8

Abstract

Background: Gonadotropin-releasing hormone (GnRH) plays essential roles in embryo implantation, invasion of trophoblastic tissue, and steroid synthesis in the placenta. Objective: The aim of this study was to evaluate the effect of GnRH antagonist administration on pregnancy outcomes in early implantation period. Materials and Methods: In this retrospective study, 94 infertile women undergoing GnRH antagonist protocol who were at risk of ovarian hyperstimulation syndrome (OHSS) were included. Sixty-seven patients (group I) received Cetrorelix 0.25 mg/daily in the luteal phase for 3 days while in 27 participants (group II), it was not administered. Pregnancy outcomes were assessed based on chemical and clinical pregnancy rates. Results: The pregnancy outcomes were not significantly different between two groups (p=0.224). Conclusion: The present study proposed that luteal phase GnRH antagonist administration does not influence the chance of successful pregnancy outcomes.

Authors and Affiliations

Maryam Eftekhar, Sepideh Miraj, Zahrasadat Mortazavifar

Keywords

Related Articles

The frequency of gonorrheal and chlamydial infections in Zanjanian women in 2013-2014

Background: Chlamydia trachomatis and Neisseria gonorrhoeae are the most prevalent bacterial sexually transmitted diseases in women. Objective: The purpose of this study was to investigate the prevalence of gonorrheal an...

Revealing the secret life of pre-implantation embryos by time-lapse monitoring: A review

High implantation success following in vitro fertilization cycles are achieved via the transfer of embryos with the highest developmental competence. Multiple pregnancies as a result of the transfer of several embryos pe...

SULF 1 gene polymorphism, rs6990375 is in significant association with fetus failure in IVF technique

Background: Sulfatase 1 (SULF1) function is to remove the 6-O-sulphate group from heparan sulfate. This action changes the binding sites of extracellular growth factors. SULF1 expression has been reported to be changed i...

Effects of human menopausal gonadotropin on zona pellucida and pregnancy outcomes of ovarian stimulation protocols

Background: Human menopausal gonadotropin (hMG) has contributed many improvements to human assisted reproduction. However, effects of hMG on oocyte development and clinical results remain controversial. Objective: This s...

Gaining comprehensive data about sexual knowledge through surveys

Background: Delivery of sexual health services rely on rigorous facts extracted from surveys, but often those facts cannot be available due to the lack of culturally-sensitive questionnaires. Objective: our aim was to sh...

Download PDF file
  • EP ID EP185893
  • DOI -
  • Views 132
  • Downloads 0

How To Cite

Maryam Eftekhar, Sepideh Miraj, Zahrasadat Mortazavifar (2016). The effect of luteal phase gonadotropin-releasing hormone antagonist administration on IVF outcomes in women at risk of OHSS. International Journal of Reproductive BioMedicine, 14(8), 507-510. https://www.europub.co.uk/articles/-A-185893